Koninklijke Philips (PHG) Cash from Investing Activities Growth (3y) (2012 - 2025)

Koninklijke Philips (PHG) Cash from Investing Activities Growth (3y) (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -253.01%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -11.91%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -41.67%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -111.03%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -40.94%
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -2.10%

Historic Data

Download Data
DateValue
Dec 31, 2025 17.31%
Jun 30, 2025 35.19%
Dec 31, 2024 47.37%
Jun 30, 2024 54.49%
Dec 31, 2023 23.20%
Jun 30, 2023 13.37%
Dec 31, 2022 -31.48%
Jun 30, 2022 -21.27%
Dec 31, 2021 -35.30%
Jun 30, 2021 -73.19%
Dec 31, 2020 26.25%
Jun 30, 2020 -13.31%
Dec 31, 2019 17.28%
Jun 30, 2019 2.04%
Dec 31, 2018 7.28%
Jun 30, 2018 23.57%
Dec 31, 2017 -45.22%
Jun 30, 2016 1.11%
Mar 31, 2016 5.82%
Dec 31, 2015 -21.04%